New therapy aims to ease long COVID symptoms

NCT ID NCT06231238

First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This study tests a type of talking therapy called Balance ACT for people with long COVID. The therapy uses mindfulness and goal-setting to help manage symptoms like fatigue and sleep problems. 196 adults with long COVID will either get the therapy or a self-help leaflet. The main goal is to see if the therapy improves quality of life after 14 weeks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Balance Acceptance and Commitment Therapy (ACT)
What this could lead to
If it works, this could offer a new psychological approach to help people with long COVID manage symptoms and improve daily life.
What could go wrong
This is a relatively small, early-stage trial testing a behavioral therapy, not a drug. Results may not apply to everyone, and the therapy may not work for all participants.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LONG COVID are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • King's College London

    Camberwell, London, SE5 8AF, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.